| pubmed-article:17947722 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17947722 | lifeskim:mentions | umls-concept:C0812413 | lld:lifeskim |
| pubmed-article:17947722 | lifeskim:mentions | umls-concept:C0672663 | lld:lifeskim |
| pubmed-article:17947722 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:17947722 | pubmed:issue | 30 | lld:pubmed |
| pubmed-article:17947722 | pubmed:dateCreated | 2007-10-19 | lld:pubmed |
| pubmed-article:17947722 | pubmed:abstractText | Malignant pleural mesothelioma (MPM) is a disease of increasing incidence for which treatment options are limited. This study reports the clinical efficacy data for vinflunine, a novel microtubule inhibitor, in MPM. | lld:pubmed |
| pubmed-article:17947722 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17947722 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947722 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17947722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17947722 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17947722 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:17947722 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:RuffiéPierreP | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:RivièreAlainA | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:TalbotDenis... | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:MargeryJacque... | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:DarkGrahamG | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:TaylorHenryH | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:DabouisGérard... | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:OllivierLilia... | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:PinelMarie-Cl... | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:BoussemartHél... | lld:pubmed |
| pubmed-article:17947722 | pubmed:author | pubmed-author:CadicVéroniqu... | lld:pubmed |
| pubmed-article:17947722 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17947722 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:17947722 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:17947722 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17947722 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17947722 | pubmed:pagination | 4751-6 | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:meshHeading | pubmed-meshheading:17947722... | lld:pubmed |
| pubmed-article:17947722 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17947722 | pubmed:articleTitle | Phase II study of vinflunine in malignant pleural mesothelioma. | lld:pubmed |
| pubmed-article:17947722 | pubmed:affiliation | Cancer Research UK Medical Oncology Unit, Churchill Hospital, Headington, Oxford, United Kingdom. denis.talbot@cancer.org.uk | lld:pubmed |
| pubmed-article:17947722 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17947722 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17947722 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17947722 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17947722 | lld:pubmed |
